22h
Medpage Today on MSNWhat's the Better Option for High-Risk Prostate Cancer -- Radiation or Surgery?Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Delcath Systems, Inc. ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update to the ...
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...
Broccoli sprouts are three or four-day-old broccoli plants, often used in salads and known for their radish-like taste. They ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.
The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...
7h
Livewire Markets on MSNAfter a 200% rise in a year, does Pro Medicus have another gear?We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results